Regulatory Strategy Executive – Cell & Gene Therapy (Hybrid)

Vertex Pharmaceuticals

Boston (MA)

Hybrid

USD 268,200 - 402,200

Full time

14 days+
Application generator

Turn this role into an interview — a resume and cover letter built around what this employer wants.

Get past ATS filters

Benefits offered by this job

Annual bonus
Annual equity awards
Hybrid-Eligible or On-Site

Job summary

Vertex Pharmaceuticals is seeking an Executive Director of Regulatory Strategy for its Cell & Gene Therapy portfolio focused on Type 1 Diabetes. This global leadership role manages a team of regulatory professionals and drives innovative strategies for development and commercialization.

A strong track record in pharmacovigilance, submissions, and health authority interactions is essential, with hybrid work options available.

Qualifications

  • Bachelor's degree required in Biology, Chemistry, or related discipline.
  • 15+ years in pharmaceutical/biotech regulatory affairs; 7+ years in supervision/management.
  • Experience leading regulatory strategy for complex programs across development stages.

Responsibilities

  • Lead global/regional regulatory strategy for multiple T1D projects from FIH to post-market.
  • Coordinate with cross-functional teams to align regulatory plans with corporate objectives.
  • Contribute to regulatory submissions, health authority communications, and guidance documents.
  • Mentor and develop staff, manage timelines and budget, and optimize processes.

Skills

Regulatory strategy
Drug development
Team leadership
Strategic communication
Health authority liaison

Education

Bachelor's degree in Biology, Chemistry, or related field

Job description

Vertex Pharmaceuticals is seeking an Executive Director of Regulatory Strategy for its Cell & Gene Therapy portfolio focused on Type 1 Diabetes. This global leadership role manages a team of regulatory professionals and drives innovative strategies for development and commercialization.

A strong track record in pharmacovigilance, submissions, and health authority interactions is essential, with hybrid work options available.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Regulatory Strategy Director, Cell & Gene Therapy (Hybrid)
Regulatory Strategy Director, Cell & Gene Therapy (Hybrid)

Vertex Pharmaceuticals • Washington

Hybrid
USD 268,000 - 403,000
Executive Director, Global Regulatory Strategy — CGT Hybrid
Executive Director, Global Regulatory Strategy — CGT Hybrid

Biopharma Careers • Boston (MA)

Hybrid
USD 268,000 - 402,000
Global Commercial Supply Chain Director (Hybrid)
Global Commercial Supply Chain Director (Hybrid)

Vertex Pharmaceuticals Incorporated • Boston (MA)

Hybrid
USD 182,000 - 273,000
Global Regulatory Strategy Director - Cell & Gene Therapy
Global Regulatory Strategy Director - Cell & Gene Therapy

Scorpion Therapeutics • Washington

On-site
USD 230,000 - 320,000
Commercial Supply Chain Director - Cell & Gene Therapy
Commercial Supply Chain Director - Cell & Gene Therapy

Vertex Pharmaceuticals • Boston (MA)

On-site
USD 182,000 - 273,000
Annual bonus
Equity awards
Commercial Supply Chain Director, Cell & Gene Therapy
Commercial Supply Chain Director, Cell & Gene Therapy

Biopharma Careers • Boston (MA)

Hybrid
USD 182,000 - 273,000
Hybrid-Eligible
On-Site Eligible
Bonus & Equity
+1
Regulatory Strategy Leader — Gene Therapy
Regulatory Strategy Leader — Gene Therapy

Genetix Biotherapeutics • Somerville (MA)

Hybrid
USD 265,000 - 331,000
Global Gene Therapy Regulatory Strategy Director (Hybrid)
Global Gene Therapy Regulatory Strategy Director (Hybrid)

Scorpion Therapeutics • Boston (MA)

Hybrid
USD 180,000 - 240,000
Executive Director, Regulatory Strategy, Cell & Gene Therapy
Executive Director, Regulatory Strategy, Cell & Gene Therapy

Vertex Pharmaceuticals • Washington

Hybrid
USD 268,000 - 403,000
Executive Director, Regulatory Strategy, Cell & Gene Therapy
Executive Director, Regulatory Strategy, Cell & Gene Therapy

Biopharma Careers • Boston (MA)

Hybrid
USD 268,000 - 402,000